Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 7.2%. Looking ahead, revenue is forecast to grow 1.0% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Global Tobacco industry.

Shares of Altria Group dipped 0.3% to $52.51. The cigarette manufacturer reported earnings of $1.29 a share on revenue of $5.1 billion, in line with FactSet consensus estimates. F

Altria said it may not be able to meet its 2028 business projections for the category due to a “challenging” operating environment, citing unsanctioned rivals. It may also fal

Bank of America Securities analyst Lisa Lewandowski reiterated a Buy rating on Altria Group (MO – Research Report) yesterday and set a price

Marlboro and Juul owner Altria Group (MO) said about 60% of the market for e-vapes is counterfeit and it’s having a damaging effect on

Altria Group reported a double beat in Q4, driven by strong growth from its on! brand. Read more to see why I remain bullish on MO stock.

Good day, and welcome to the Altria Group 2024 fourth quarter and full year earnings conference call. [Operator instructions] I would now like to turn the call over to Mac Livingston, vice president of investor relations for Altria Client Services. Please go ahead, sir.

A U.S. trade tribunal sided with Juul Labs on Wednesday and ordered a ban on imports of vaping devices and cartridges made by Altria's NJOY - at least some of which are made in China and Malaysia - in a patent dispute over e-cigarette technology.

Altria remains positioned to generate $8.3 billion in attributable cash flow, likely sustaining a highly attractive ~10% shareholder yield. Learn more on MO stock here.

Juul Labs’ Chief Legal Officer says ruling sends a ‘clear message that this freeriding violates U.S. law and American innovation will be

The cigarette giant beat expectations for the fourth quarter by a slender margin, but saw growth in its smoke-free product segments.

Altria profit rose in the fourth quarter, with revenue flat as lower smokeable-product sales were offset by higher oral-tobacco revenue. The maker of Marlboro cigarettes reported on Thursday a profit of $3.04 billion, or $1.79 a share, up from $2.06 billion, or $1.16 a share, in the year-prior period.